相关实验视频
Updated: May 20, 2025

07:42
Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
17.3K
抗癌纳米颗粒 载体的 代性蛋白质 细胞c
Alexandar M Zhivkov1, Svetlana H Hristova2,3, Trifon T Popov4
1Scientific Research Center, "St. Kliment Ohridski" Sofia University, 8 Dragan Tsankov Blvd., 1164 Sofia, Bulgaria.
Pharmaceutics
|March 27, 2025
概括
本综述探讨了用于癌症治疗的带有细胞染色体c (cytC) 的复合纳米粒子. 这些纳米颗粒诱导癌细胞的亡,为表面瘤提供选择性和无毒的治疗方法.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 细胞染色体c (cytC) 是一种线粒体蛋白质,具有双重作用:电子运输和亡诱导.
- 癌细胞可以通过纳米颗粒将外源性cytC内部化,从而触发已编程的细胞死亡 (细胞亡).
- 复合纳米粒子为向癌症治疗提供了一种新的策略.
研究的目的:
- 审查关于cytC载纳米颗粒的合成,特性和细胞毒性的文献.
- 评估这些纳米粒子在治疗表面癌症方面的潜力.
- 讨论影响细胞毒性的因素和增强细胞毒性的方法.
主要方法:
- 关于cytC复合纳米粒子研究的文献综述.
- 对含有cytC的合物和纳米颗粒的合成技术的分析.
- 批判性评估报告的细胞毒性数据和影响物理化学性能的数据.
主要成果:
- 携带CytC的纳米颗粒可以在癌细胞中启动细胞亡.
- 这种方法显示了对表面瘤的选择性和无毒治疗的潜力.
- 纳米颗粒的物理化学特性显著影响它们的细胞毒性.
结论:
- CytC复合纳米粒子代表了针对性癌症治疗的有前途的战略.
- 由于cytC的选择性和安全性,它在抗癌应用中具有优势.
- 对优化纳米粒子特性进行进一步的研究对于临床转化至关重要.
更多相关视频
相关概念视频
The Intrinsic Apoptotic Pathway
5.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.8K
The Extrinsic Apoptotic Pathway
5.7K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.7K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Electron Transport Chain: Complex I and II
9.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.8K
Phagocytosis of Apoptotic Cells
3.2K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.2K

